De novo design of protein target specific scaffold-based Inhibitors via Reinforcement Learning

05/21/2022
by   Andrew D. McNaughton, et al.
0

Efficient design and discovery of target-driven molecules is a critical step in facilitating lead optimization in drug discovery. Current approaches to develop molecules for a target protein are intuition-driven, hampered by slow iterative design-test cycles due to computational challenges in utilizing 3D structural data, and ultimately limited by the expertise of the chemist - leading to bottlenecks in molecular design. In this contribution, we propose a novel framework, called 3D-MolGNN_RL, coupling reinforcement learning (RL) to a deep generative model based on 3D-Scaffold to generate target candidates specific to a protein building up atom by atom from the starting core scaffold. 3D-MolGNN_RL provides an efficient way to optimize key features by multi-objective reward function within a protein pocket using parallel graph neural network models. The agent learns to build molecules in 3D space while optimizing the activity, binding affinity, potency, and synthetic accessibility of the candidates generated for infectious disease protein targets. Our approach can serve as an interpretable artificial intelligence (AI) tool for lead optimization with optimized activity, potency, and biophysical properties.

READ FULL TEXT
research
05/27/2020

PaccMann^RL on SARS-CoV-2: Designing antiviral candidates with conditional generative models

With the fast development of COVID-19 into a global pandemic, scientists...
research
11/04/2022

De novo PROTAC design using graph-based deep generative models

PROteolysis TArgeting Chimeras (PROTACs) are an emerging therapeutic mod...
research
11/30/2021

Decoding the Protein-ligand Interactions Using Parallel Graph Neural Networks

Protein-ligand interactions (PLIs) are fundamental to biochemical resear...
research
10/04/2021

Hit and Lead Discovery with Explorative RL and Fragment-based Molecule Generation

Recently, utilizing reinforcement learning (RL) to generate molecules wi...
research
05/27/2020

Targeted design of antiviral compounds against SARS-CoV-2 with conditional generative models

With the fast development of COVID-19 into a global pandemic, scientists...
research
03/06/2023

3D Equivariant Diffusion for Target-Aware Molecule Generation and Affinity Prediction

Rich data and powerful machine learning models allow us to design drugs ...
research
11/28/2022

Reinforced Genetic Algorithm for Structure-based Drug Design

Structure-based drug design (SBDD) aims to discover drug candidates by f...

Please sign up or login with your details

Forgot password? Click here to reset